Subhash Thakur, MD
Vascular Surgery · Marshall, MINPI 1770770216
Payments from drug & device makers
Across 35 payments — averaging $52.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$1K
- Medtronic$424
- Johnson & Johnson$165
- Tactile Systems Technology Inc$57
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$32
- Argon Medical Devices, Inc.$30
- plus $97 from 7 others
What the payments were for
- Travel & lodging$79543%
- Food & beverage$68537%
- Education$36420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 5 | $1,040 |
| Medtronic(2 entities) | 10 | $424 |
| Johnson & Johnson | 7 | $165 |
| Tactile Systems Technology Inc | 2 | $57 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $32 |
| Argon Medical Devices, Inc. | 2 | $30 |
| BD | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $15 |
| Reflow Medical Inc | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $13 |
| Getinge USA Sales, LLC | 1 | $12 |
| Advanced Critical Devices, Inc. | 1 | $11 |
How this compares
$1,844 in reported general payments places this provider in the 30th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 57 | $50,876 |
| EliquisApixaban | 42 | $41,328 |
| ClopidogrelClopidogrel Bisulfate | 97 | $1,397 |
| Nifedipine ErNifedipine | 37 | $858 |
| Cilostazol | 18 | $376 |
| Atorvastatin Calcium | 29 | $238 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $78 |
| Levofloxacin | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $165 | $50,87657 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 183 vascular surgery providers in Michigan.
Other vascular surgery in Marshall
- Nicolas MouawadWest Branch$2.6M
- Enrique Criado PallaresMidland$800K
- Vikram KashyapGrand Rapids$421K
- Andrea ObiAnn Arbor$404K
- Jordan KnepperEast Lansing$386K
- Chandu VemuriAnn Arbor$346K
- Eanas YassaGrand Rapids$185K
- Loay KabbaniDetroit$176K
- Judith LinDetroit$98K
- Joseph CuppariClinton Township$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.